The plot thickens: Easou eyes ChatGPT tech to write e-books
The Chinese e-reading platform wants to develop the literary potential of AI, citing ChatGPT for the first time in a Hong Kong IPO filing Key Takeaways: Easou Technology has applied…
Laekna IPO hopes to hitch a ride on Novartis ties
The producer of drugs licensed from third parties is banking on ties to the Swiss drug maker, as one of its key products nears the regulatory finish line Key Takeaways:…
Lab testing chain Adicon joins IPO rush as Covid cash dwindles
One of China’s biggest independent laboratory operators is trying to jump on the Hong Kong IPO bandwagon before its Covid testing revenues tumble Key takeaways: Adicon’s Covid test services powered…
Tianneng joins Swiss listing bandwagon, even as frosty reception awaits
The battery maker could become the 11th Chinese company to list global depositary receipts (GDRs) in Switzerland, heeding Beijing’s call for companies to raise their global profile Key Takeaways: Tianneng…
0819.HK
688819.SHG
Testing times for diagnostics firm UGenix as Covid demand drops
The medical technology company is looking to list in Hong Kong after a windfall from Covid testing, but its other screening services are not yet lucrative Key Takeaways: Covid tests…
FWD touts growth as IPO campaign drags on. But investors may want more
The Hong Kong-based regional insurer said the value of its new business grew 29% in 2022, even as its annual premium and fee income fell 15% Key Takeaways: The value…
Kelun-Biotech hopes for IPO booster from new Merck partnership
The company welcomed Merck as new shareholder not long after the pair signed a lucrative licensing agreement for its cutting-edge ADC cancer treatment Key Takeaways: Despite a lack of products…
002422.SHE
